1,677
Views
42
CrossRef citations to date
0
Altmetric
Laboratory Study

Nec-1 Protects against Nonapoptotic Cell Death in Cisplatin-Induced Kidney Injury

, , , , &
Pages 373-377 | Received 12 Aug 2011, Accepted 01 Nov 2011, Published online: 20 Jan 2012

REFERENCES

  • Lines SW, Cherukuri A, Murdoch SD, Bellamy MC, Lewington AJ. The outcomes of critically ill patients with acute kidney injury receiving renal replacement therapy. Int J Artif Organs. 2011;34(1):2–9.
  • Havasi A, Borkan S. Apoptosis and acute kidney injury. Kidney Int. 2011;80:29–40.
  • Kinsey GR, Okusa MD. Pathogenesis of acute kidney injury: Foundation for clinical practice. Am J Kidney Dis. 2011;58(2):291–301.
  • Ueda N, Shah SV. Tubular cell damage in acute renal failure-apoptosis, necrosis, or both. Nephrol Dial Transplant. 2000;15(3):318–323.
  • Degterev A, Huang Z, Boyce M, . Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112–119.
  • Li Y, Yang X, Ma C, Qiao J, Zhang C. Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons. Neurosci Lett. 2008;447(2–3):120–123.
  • Han W, Xie J, Li L, Liu Z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009;14(5):674–686.
  • Xu X, Chua KW, Chua CC, Liu CF, Hamdy RC, Chua BH. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res. 2010;1355:189–194.
  • Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM. Necrostatin: A potentially novel cardioprotective agent? Cardiovasc Drugs Ther. 2007;21(4):227–233.
  • Bao L, Li Y, Deng SX, Landry D, Tabas I. Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. J Biol Chem. 2006;281(44):33635–33649.
  • Tabas I. A two-carbon switch to sterol-induced autophagic death. Autophagy 2007;3(1):38–41.
  • Vandenabeele P, Declercq W, Vanden Berghe T. Necrotic cell death and ‘necrostatins’: Now we can control cellular explosion. Trends Biochem Sci. 2008;33(8):352–355.
  • Teng X, Degterev A, Jagtap P, . Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 2005;15(22):5039–5044.
  • Cummings BS, Schnellmann RG. Cisplatin-induced renal cell apoptosis: Caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther. 2002;302(1):8–17.
  • Sanz AB, Santamaría B, Ruiz-Ortega M, Egido J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008;19(9):1634–1642.
  • Galluzzi L, Kroemer G. Necroptosis: A specialized pathway of programmed necrosis. Cell 2008;135(7):1161–1163.
  • Cummings BS, Kinsey GR, Bolchoz LJ, Schnellmann RG. Identification of caspase-independent apoptosis in epithelial and cancer cells. J Pharmacol Exp Ther. 2004;10(1):126–134.
  • Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119(5):1275–1285.
  • Moonen M, Fraipont V, Radermacher L, Masset C, Firre E, Warling X. Acute kidney injury: From concept to practice. Nephrol Ther. 2010; 7(3):172–177.
  • Dirkes S. Acute kidney injury: Not just acute renal failure anymore? Crit Care Nurse. 2011;31(1):37–50.
  • Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17(6):1503–1520.
  • Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation 2002;73(11):1693–1700.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.